TP53 and breast carcinoma: Indeed, while mutation of p53 appears a seminal event in carcinogenesis and is present in ~30% of breast carcinoma patients, it is still unclear why only a subset of p53 mutation-positive breast carcinoma patients (~50%) generates anti-p53 AAbs [27].